Search
for
Sort by
Research 181–210 of 777
- From a stem-cell–centered to a niche-centered view: the core role of collagen networks in hair loss and hair follicle miniaturization
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Role of janus kinase inhibitors in the treatment of alopecia areata
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Mesenchymal-epidermal interactions in hair follicle cycling and regeneration
- Review of Promising Off-Label Use of Deucravacitinib
- A review of Janus kinase inhibitor use in scarring alopecia
- Application of Baricitinib in Dermatology
- Janus kinase inhibitors for alopecia areata: A narrative review
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Citrullination at the Inflammatory Skin Barrier
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Baricitinib: A Review in Severe Alopecia Areata
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Effects of Natural Herbal Marker Compounds on Human Dermal Papilla Cell Growth Regulation
- Immune therapies for alopecia areata: evidence and new perspectives
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Upadacitinib for the treatment of alopecia areata – A case report
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review